Mar 14, 2019 - Metastasis is the common thread driving cancer deaths across disease sites. New technologies have come together to create an exciting opportunity to accelerate our understanding of metastasis and our ability to improve patient outcomes. The advanced technologies include organoids, metastasis mouse models, imaging, genetics, single-cell genomics, liquid biopsies, and novel clinical trials. These methods enable us to accelerate dramatically our efforts to develop new strategies to prevent and treat metastatic cancer. To capitalize on these advances, the SKCCC is launching a new and exciting discovery program in the Cancer Center called Cancer Invasion and Metastasis (CIM). CIM will be led by co-directors Andrew Ewald, Ph.D., Professor of Cell Biology, Biomedical Engineering and Oncology, Phuoc Tran, M.D., Ph.D., Associate Professor of Radiation Oncology and Molecular Radiation Sciences, Urology and Oncology and Ashani T. Weeraratna, PhD, Chair of Biochemistry & Molecular Biology, BSPH and Bloomberg Distinguished Professor. This new research program will bring together diverse techniques and perspectives to understand the cell and molecular biology of cancer invasion and metastasis. It will be critical to combine forces across disciplines, including basic sciences, engineering, translational, and clinical areas of the Cancer Center.